A detailed history of Beryl Capital Management LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Beryl Capital Management LLC holds 420,836 shares of CTLT stock, worth $23.7 Million. This represents 30.04% of its overall portfolio holdings.

Number of Shares
420,836
Holding current value
$23.7 Million
% of portfolio
30.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$42.56 - $59.82 $17.9 Million - $25.2 Million
420,836 New
420,836 $23.8 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.1B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Beryl Capital Management LLC Portfolio

Follow Beryl Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beryl Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beryl Capital Management LLC with notifications on news.